In stage N0-1 nasopharyngeal cancer, elective upper-neck irradiation provides outcomes on par with whole-neck irradiation and with significantly lower rates of long-term toxicity, according to ...
Penpulimab-kcqx is approved for first-line treatment of recurrent or metastatic non-keratinizing NPC in combination with cisplatin or carboplatin and gemcitabine. As a single agent, penpulimab-kcqx is ...
MRI showed more than 90% sensitivity in detecting nasopharyngeal carcinoma (NPC), surpassing endoscopy’s detection rate of 65 ...
Loqtorzi combined with chemotherapy nearly doubled median overall survival in nasopharyngeal carcinoma patients compared to chemotherapy alone, with a median survival of 64.8 months. The combination ...
Mark James, age 59, is a distance runner. One of his favorite races is the Blue Ridge Relay through the Blue Ridge Mountains of North Carolina, his home state. James grew up in rural eastern North ...
Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...
(RTTNews) - Biopharmaceutical company Akeso Inc. (AKESF) said in a statement that its Penpulimab has been approved for the first-line treatment of recurrent or metastatic nasopharyngeal cancer or NPC, ...
Nonmelanoma Cutaneous Head and Neck Cancer and Merkel Cell Carcinoma: Current Concepts, Advances, and Controversies Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy arising from the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Individuals ...
A research team, led by Professor Dai Wei (front right), has discovered that the Epstein-Barr virus (EBV), a common human virus closely linked to nasopharyngeal carcinoma (NPC), can change the 3D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results